Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Corpus Uteri Carcinoma
Female
Corpus Uteri Carcinoma
Trial Information
Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
Inclusion Criteria:
- Patients whose treatment is provided to Centre Oscar Lambret
- With a corpus uteri adenocarcinoma, no metastatic, treated by:
- Surgery and observation without complementary treatment or
- Surgery and adjuvant radiotherapy or
- Surgery and curietherapy of vaginal dome
- With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
- External radiochemotherapy and curietherapy or
- Only surgery or
- Pre-surgical curietherapy and surgery
- Age > 18 years
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Toxicities including on sexual function
Outcome Description:
According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary
Outcome Time Frame:
up to 3 years
Safety Issue:
No
Principal Investigator
Philippe NICKERS, MD
Investigator Role:
Study Director
Investigator Affiliation:
Oscar Lambret Center
Authority:
France: The Commission nationale de l’informatique et des libertés
Study ID:
SEXUTOX
NCT ID:
NCT01650987
Start Date:
May 2009
Completion Date:
December 2015
Related Keywords:
- Corpus Uteri Carcinoma
- carcinoma
- uterus
- Not metastatic
- Carcinoma
- Uterine Neoplasms
Name | Location |
|---|
